Yet, analysis of sequencing repositories from large tumor panels, including deep sequencing initiatives, does not highlight the preferential selection of mutation or copy number variation in the P2RX7 gene by tumor cells (Lawrence et al., 2014). The gene discussed is P2RX7; the disease is neoplasm.